- Executive chair of the board of EIP Pharma, Inc.
- Member of the board of Perkin Elmer Inc.
- Member of the board of F2G Ltd.
- President of Human Genetic Therapies Shire PLC, 2007-2013.
- Executive chair of IDM Pharma Inc., 2006-2007.
- President and chief executive officer in GlycoFi Inc., 2003-2004.
- Considered independent under the Danish Recommendations on Corporate Governance.
- Member of the Board of Directors since March 2015. Most recently elected in 2022 for a term of one year.
- Member of the Audit Committee since March 2015. The Board has assessed that Ms Grégoire qualifies as independent pursuant to the US Securities Exchange Act.
- Member of the Research & Development Committee since March 2017.
- Member of the Nomination Committee since March 2018.
- Global corporate leadership
- Healthcare and pharma industry
- Medicine & science
- Finance & accounting
- Business development, M&A and external innovation sourcing
- Human capital management
- 1986: Pharmacy Doctorate degree, the State University of NY at Buffalo, US,
- 1984: BA in Pharmacy, Laval University, Canada.
- 1980: Science College degree, Séminaire de Sherbrooke, Canada.
Canadian and US national, born 1961. Female.
